Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation

(European Society of Cardiology) Apixaban and warfarin are equally safe during catheter ablation of atrial fibrillation, according to results of the AXAFA-AFNET 5 trial presented today in a late-breaking trial session at EHRA 2018, a European Society of Cardiology (ESC) congress.1 There were similar rates of stroke and bleeding, and an improvement in cognitive function was shown for the first time.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news